722 related articles for article (PubMed ID: 18783534)
21. Hypoactive sexual desire disorder in postmenopausal women.
Nappi RE; Wawra K; Schmitt S
Gynecol Endocrinol; 2006 Jun; 22(6):318-23. PubMed ID: 16785156
[TBL] [Abstract][Full Text] [Related]
22. A case series of androgen use in breast cancer survivors with sexual dysfunction.
Krychman ML; Stelling CJ; Carter J; Hudis CA
J Sex Med; 2007 Nov; 4(6):1769-74. PubMed ID: 17666036
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of transdermal testosterone in postmenopausal women with hypoactive sexual desire disorder: a systematic review and meta-analysis.
Achilli C; Pundir J; Ramanathan P; Sabatini L; Hamoda H; Panay N
Fertil Steril; 2017 Feb; 107(2):475-482.e15. PubMed ID: 27916205
[TBL] [Abstract][Full Text] [Related]
24. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ; Simon JA; Davis SR; Giraldi A; Goldstein I; Goldstein SW; Kim NN; Kingsberg SA; Morgentaler A; Nappi RE; Park K; Stuenkel CA; Traish AM; Vignozzi L
J Womens Health (Larchmt); 2021 Apr; 30(4):474-491. PubMed ID: 33797277
[No Abstract] [Full Text] [Related]
25. Validation of a Women's Sexual Interest Diagnostic Interview--Short Form (WSID-SF) and a Daily Log of Sexual Activities (DLSA) in postmenopausal women with hypoactive sexual desire disorder.
DeRogatis LR; Allgood A; Auerbach P; Eubank D; Greist J; Bharmal M; Zipfel L; Guo CY
J Sex Med; 2010 Feb; 7(2 Pt 2):917-27. PubMed ID: 19832932
[TBL] [Abstract][Full Text] [Related]
26. Androgens, health and sexuality in women and men.
Wylie K; Rees M; Hackett G; Anderson R; Bouloux PM; Cust M; Goldmeier D; Kell P; Terry T; Trinick T; Wu F
Maturitas; 2010 Nov; 67(3):275-89. PubMed ID: 20851539
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
[TBL] [Abstract][Full Text] [Related]
28. The safety of testosterone therapy in women.
Al-Imari L; Wolfman WL
J Obstet Gynaecol Can; 2012 Sep; 34(9):859-865. PubMed ID: 22971455
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and evaluation of sexual health problems--HSDD in Europe.
Graziottin A
J Sex Med; 2007 Mar; 4 Suppl 3():211-9. PubMed ID: 17394593
[TBL] [Abstract][Full Text] [Related]
30. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.
Panay N; Al-Azzawi F; Bouchard C; Davis SR; Eden J; Lodhi I; Rees M; Rodenberg CA; Rymer J; Schwenkhagen A; Sturdee DW
Climacteric; 2010 Apr; 13(2):121-31. PubMed ID: 20166859
[TBL] [Abstract][Full Text] [Related]
31. Testosterone for low libido in postmenopausal women not taking estrogen.
Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
[TBL] [Abstract][Full Text] [Related]
32. Management of female sexual dysfunction in postmenopausal women by testosterone administration: safety issues and controversies.
Braunstein GD
J Sex Med; 2007 Jul; 4(4 Pt 1):859-66. PubMed ID: 17627735
[TBL] [Abstract][Full Text] [Related]
33. International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women.
Parish SJ; Simon JA; Davis SR; Giraldi A; Goldstein I; Goldstein SW; Kim NN; Kingsberg SA; Morgentaler A; Nappi RE; Park K; Stuenkel CA; Traish AM; Vignozzi L
Climacteric; 2021 Dec; 24(6):533-550. PubMed ID: 33792440
[TBL] [Abstract][Full Text] [Related]
34. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.
Buster JE; Kingsberg SA; Aguirre O; Brown C; Breaux JG; Buch A; Rodenberg CA; Wekselman K; Casson P
Obstet Gynecol; 2005 May; 105(5 Pt 1):944-52. PubMed ID: 15863529
[TBL] [Abstract][Full Text] [Related]
35. Comparison of androgens in women with hypoactive sexual desire disorder: those on combined oral contraceptives (COCs) vs. those not on COCs.
Warnock JK; Clayton A; Croft H; Segraves R; Biggs FC
J Sex Med; 2006 Sep; 3(5):878-882. PubMed ID: 16942531
[TBL] [Abstract][Full Text] [Related]
36. A double-blind, randomized, placebo-controlled trial of the effect of testosterone cream on the sexual motivation of menopausal hysterectomized women with hypoactive sexual desire disorder.
El-Hage G; Eden JA; Manga RZ
Climacteric; 2007 Aug; 10(4):335-43. PubMed ID: 17653960
[TBL] [Abstract][Full Text] [Related]
37. Androgen treatment of postmenopausal women.
Davis SR; Worsley R
J Steroid Biochem Mol Biol; 2014 Jul; 142():107-14. PubMed ID: 23727129
[TBL] [Abstract][Full Text] [Related]
38. Endocrine aspects of female sexual dysfunction.
Davis SR; Guay AT; Shifren JL; Mazer NA
J Sex Med; 2004 Jul; 1(1):82-6. PubMed ID: 16422987
[TBL] [Abstract][Full Text] [Related]
39. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
[TBL] [Abstract][Full Text] [Related]
40. Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: a controlled pilot study of the effects on the arizona sexual experiences scale for females and sexual function questionnaire.
Chudakov B; Ben Zion IZ; Belmaker RH
J Sex Med; 2007 Jan; 4(1):204-208. PubMed ID: 17233786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
